Revvity for Diagnostics

Join our LinkedIn LIVE with experts as we dive into the latest advances in rare disease research, diagnosis, and advocacy. Together, we can make an impact! Panelists: Dr. Lora Bean, Kayla Banks, Dr. Holly Peay Mark your calendars for Feb. 28! #RareDiseaseAwareness #RareDiseaseDay

The NEXTFLEX? Small RNA-Seq Kit v4 enables labs to get a higher proportion of mapped reads and unique miRNAs with a gel-free protocol, even with low input samples. Optimized for low input samples such as plasma or serum, even exosomes. Learn more: https://ms.spr.ly/6047qDUyX For research use only. Not for use in diagnostic procedures. #SmallRNA #miRNA #LowInput

Choosing the right testing platform is crucial! #CNGnomeNGSArray reveals critical insights often missed by traditional #arrays. Now available in India, the CNGnome? NGS Array by #Revvity Omics offers a next-gen #wholegenome approach for reliable #CNV detection, enhancing precision and patient care. Reach out to our team at [email protected] to know more! #GeneticTesting #genome #NGS #CNGnome #NGS https://ms.spr.ly/6042UKSWr

What if a simple test at birth could change a life? Nola & Teddi were both born with Metachromatic Leukodystrophy (#MLD), but only one received life-changing treatment—thanks to #newbornscreening. Hear their mother, Ally Wallace, share their journey & why early detection matters. #RareDiseaseAwareness https://ms.spr.ly/6047UhR2W

This winter, I had the privilege of meeting a beautiful family through my child's hobby. Their warmth and resilience left a lasting impression on me. Their child has a rare condition, and they are fortunate to have received a diagnosis and treatment. However, with newborn screening, they could have received this diagnosis even earlier. Unfortunately, this condition is not yet included in the Finnish screening program. Newborn screening?has the potential to change the lives of many people with rare conditions. Today, I advocate for as many babies as possible to receive comprehensive screening. I'm also excited about the large projects exploring the feasibility of?genomic newborn screening. Using?Next-Generation Sequencing (NGS) can potentially shorten the diagnostic odyssey for hundreds of disorders in future. Meeting this family has reinforced my belief in the importance of early diagnosis and treatment. Their journey is a testament to the power of innovative research and the hope it brings to families affected by rare diseases. Let's continue to support and advocate for those living with rare diseases. Together, we can make a difference. ?? #RareDiseaseDay #NewbornScreening #GenomeSequencing #Revvity

Cloud-based NBS software, such as EVOYA?, offers secure and scalable data storage and management solutions. https://ms.spr.ly/6047UhPvV

Todayis Rare Disease Day. Read our new blog on #Revvity's commitment to rare disease awareness: https://ms.spr.ly/6049UCBcV

Tomorrow is Rare Disease Day. Read our new blog on #Revvity's commitment to rare disease awareness: https://ms.spr.ly/6049UCBgb

From gene expression analysis to variant calling, you can remove PCR duplicates and minimize error with the NEXTFLEX? UDI-UMI adapters. Ideal for multiplexing #NGS libraries for Illumina? and Element? sequencers. #Sequencing #Genomics #UMIUDI For research use only. Not for use in diagnostic procedures. https://ms.spr.ly/6040UePC4

Ribodepletion is crucial in single-cell transcriptomics studies. The DepleteX? Single Cell RNA Boost Kit allows labs to reduce noise and optimize usable data in single-cell RNA sequencing workflows by leveraging a CRISPR-based depletion technology that efficiently removes abundant and uninformative fragments before sequencing. https://ms.spr.ly/6044Ufe50 #scRNAseq #ribodepletion #CRISPRdepletion For research use only. Not for use in diagnostic procedures.